Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 81.40B | 79.11B | 81.89B | 74.10B | 69.12B | 69.80B |
Gross Profit | 13.00B | 12.50B | 12.31B | 9.59B | 10.71B | 11.05B |
EBITDA | 5.38B | 7.12B | 4.37B | 3.37B | 5.46B | 5.97B |
Net Income | 222.00M | 329.00M | -790.00M | -2.31B | -623.00M | 1.36B |
Balance Sheet | ||||||
Total Assets | 70.73B | 67.56B | 69.04B | 69.38B | 66.79B | 69.46B |
Cash, Cash Equivalents and Short-Term Investments | 17.89B | 14.78B | 14.50B | 12.22B | 10.55B | 12.71B |
Total Debt | 27.23B | 25.69B | 26.59B | 26.28B | 23.98B | 24.03B |
Total Liabilities | 50.89B | 46.12B | 49.97B | 50.13B | 45.18B | 48.31B |
Stockholders Equity | 17.39B | 18.76B | 16.45B | 16.79B | 19.38B | 19.02B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 1.74B | 2.28B | -401.00M | -1.79B | 603.00M |
Operating Cash Flow | 0.00 | 4.66B | 6.57B | 3.04B | 2.19B | 4.26B |
Investing Cash Flow | 0.00 | -3.14B | -3.76B | -3.63B | -4.38B | -3.10B |
Financing Cash Flow | 0.00 | -1.91B | -59.00M | 1.88B | -684.00M | -148.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | ¥4.41B | 8.16 | 3.48% | 0.23% | -14.50% | ||
76 Outperform | ¥2.84B | 7.95 | 3.24% | 0.23% | -16.37% | ||
71 Outperform | ¥4.34B | 7.33 | 4.89% | 7.71% | 44.35% | ||
66 Neutral | ¥3.84B | 8.48 | 4.56% | 3.82% | ― | ||
62 Neutral | $16.65B | 11.30 | -7.38% | 3.01% | 1.59% | -23.30% | |
60 Neutral | ¥3.31B | 10.09 | ― | -3.39% | ― | ||
39 Underperform | ¥3.68B | ― | ― | 33.86% | 69.12% |